The Sumaira Foundation is a 501(c)(3) organization dedicated to generating
global awareness of NMOSD* and MOG-AD*, supporting research to find a cure, and creating a community
of support for patients + their caregivers.
Neuromyelitis optica spectrum disorder (NMOSD) is a rare neuroimmune condition in which the immune system attacks cells in the central nervous system (CNS), mistaking them for foreign invaders. Common symptoms include vision loss, color vision deficiency, paralysis, paraparesis, weakness, numbness, spasticity, vomiting, hiccups, and bladder/bowel dysfunction.
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOG-AD) is a rare neuroimmune condition that targets the MOG protein which is located on the surface of myelin sheaths in the central nervous system. Common symptoms include vision loss, color vision deficiency, paralysis, paraparesis, weakness, numbness, spasticity, vomiting, hiccups, seizures, and bladder/bowel dysfunction.
Raise awareness.
Build community.
Support research.
Advocate.